Back
Successful Treatment of Recurrent Triple-Negative Breast Cancer with Combination of Targeted Therapies
Stanislaw R. Burzynski, Alejandro Marquis, Eva Nagy-Kubove, Tomasz Janicki
J. Cancer Ther. Vol.2 No.3, August 08, 2011  DOI: 10.4236/jct.2011.23050
       (PDF  674K)     HTML      XML
Early Stage Triple Negative Breast Cancer Has Significantly Better Outcomes than More Advanced Disease: A Single Centre Retrospective Review
Caroline Hamm, Swati Kulkarni, Rasna Gupta, Amin Kay, John Mathews, Khalid Hirmiz, Indryas Woldie, Akmal Ghafoor, Tarek Elfiki, Sindu Kanjeekal, Ming Pan, Kenneth Schneider, Junaid Yousuf, Mohammad Jarrar, Colvin Springer, Maher El-Masri
J. Cancer Ther. Vol.7 No.10, September 22, 2016  DOI: 10.4236/jct.2016.710069
       (PDF  860K)     HTML      XML
p53 Expression in Triple Negative Breast Carcinomas: Evidence of Age-Related and Racial Differences
Simone Davion, Megan Sullivan, Stephen Rohan, Kalliopi P. Siziopikou
J. Cancer Ther. Vol.3 No.5, October 31, 2012  DOI: 10.4236/jct.2012.325084
       (PDF  1077K)     HTML     
Clinicopathological Study of Epithelial Metaplastic Breast Cancer
Masahiro Kitada, Shunsuke Yasuda, Nana Takahashi, Satoshi Okazaki, Kei Ishibashi, Satoshi Hayashi
J. Cancer Ther. Vol.7 No.13, December 22, 2016  DOI: 10.4236/jct.2016.713100
       (PDF  379K)     HTML      XML
Treatment Patterns and Mortality Risk among Elderly Patients with Metastatic Triple Negative Breast Cancer in the United States: An Observational Cohort Study Using SEER-Medicare Data
Sacha Satram-Hoang, Preeti Bajaj, Alisha Stein, Patricia Cortazar, Faiyaz Momin, Carolina Reyes
J. Cancer Ther. Vol.10 No.2, February 15, 2019  DOI: 10.4236/jct.2019.102009
       (PDF  1168K)     HTML      XML
 
 
Top